| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c4180fc57a693864e2ce2dbfd64a9278 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0095 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10 |
| filingDate |
2014-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54a6e81e3453755c19b67feca2eeece3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_635fd633da14e96118220c26f6f3a8ac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d801ae519ce67d12dc4c3a30a178118
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fcd7e459edf2cceb4fd75eb51a339aa2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_702fb5873e491c25c1c5e82b4f649ee7 |
| publicationDate |
2015-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-201542240-A |
| titleOfInvention |
Oral liquid pharmaceutical composition comprising FEXOFENADINE |
| abstract |
The present invention relates to an oral liquid pharmaceutical composition comprising fexofenadine and/or a pharmaceutically acceptable salt thereof, polyethylene glycol or a propylene glycol based solvent or a mixture thereof. An acceptable carrier, from 35% to 90% by weight of a pharmaceutically acceptable excipient which stabilizes phenoxyphene and/or a pharmaceutically acceptable salt thereof, which is derived from glycerol and In the case of sorbitol composition. The invention also relates to the use of such compositions as medicaments and to methods of preparing such compositions. |
| priorityDate |
2013-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |